The artificial intelligence (AI) medical scribe software market size is expected to see exponential growth in the next few years. It will grow to $5.08 billion in 2030 at a compound annual growth rate (CAGR) of 27.2%. The growth in the forecast period can be attributed to ai-driven healthcare automation, telemedicine expansion, regulatory documentation needs, clinician productivity focus, cloud healthcare platforms. Major trends in the forecast period include automated clinical documentation, real-time speech recognition, workflow optimization in healthcare, ai-driven compliance support, context-aware medical transcription.
The rising prevalence of physician and clinician burnout is expected to contribute the growth of the artificial intelligence medical scribe software market going forward. Physician and clinician burnout is a condition of physical, emotional, and mental exhaustion resulting from prolonged work-related stress in healthcare environments. The increasing incidence of physician and clinician burnout is largely attributed to growing administrative workloads, where extensive documentation and electronic health record tasks limit patient interaction time, leading to stress, fatigue, and emotional exhaustion. Artificial intelligence medical scribe software addresses the rising prevalence of physician and clinician burnout by automating clinical documentation, reducing administrative pressure, and enabling clinicians to devote greater focus to patient care rather than paperwork. For instance, in December 2024, according to the Australian Journal of General Practice, an Australia-based publication, 71% of 2,000 Australian general practitioners experienced burnout in 2023. Therefore, the rising prevalence of physician and clinician burnout is expected to drive the growth of the artificial intelligence medical scribe software market.
Leading companies operating in the artificial intelligence medical scribe software market are focusing on developing innovative solutions, such as native artificial intelligence charting tools, to improve clinical documentation accuracy and support better patient care outcomes. Native artificial intelligence charting tools are integrated data visualization features powered by AI that automatically generate charts, graphs, and insights from platform data without requiring external plugins or manual coding. For example, in August 2025, Epic, a US-based electronic health records (EHR) software provider, announced the development of its native AI charting tool, which uses integrated AI to automatically populate sections of a patient’s electronic patient record (EPR), reducing documentation time and administrative workload while allowing clinicians to focus more on patient care; the technology combines Microsoft’s Dragon Ambient AI for transcription with Epic’s proprietary processing to generate structured visit documentation directly within the EPR and is expected to be available for limited use by early 2026, with additional AI features such as discharge planning agents and virtual assistants planned thereafter.
In October 2024, Commure Inc., a US-based provider of artificial intelligence-powered healthcare technology solutions, acquired Augmedix Inc. for an undisclosed amount. Through this acquisition, Commure seeks to strengthen its capabilities in ambient artificial intelligence medical documentation and consolidate a broader suite of artificial intelligence healthcare software to improve clinical efficiency and expand its market presence. Augmedix Inc. is a US-based provider of ambient, artificial intelligence-driven medical documentation and data solutions designed to reduce administrative burdens and enhance clinical workflows.
Major companies operating in the artificial intelligence (ai) medical scribe software market are TruBridge Inc, Innovaccer Inc, CureMDcom Inc, Abridge AI Inc, OmniMD Inc, Notable Health Inc, Nabla Labs Inc, Voicebrook Inc, Tandem Health AB, Sully AI Inc, Freed AI Inc, Heidi Health Pty Ltd, Ambience Healthcare Pty Ltd, Upheal Inc, Tali AI Inc, ScribeAmerica AI Inc, Playback Health Inc, SPRY Therapeutics Inc., Suki AI Inc, and Sunoh AI Inc.
Tariffs have introduced moderate cost pressures in the AI medical scribe software market by increasing prices of imported microphones, servers, and networking equipment. Healthcare providers in Asia-Pacific and parts of Europe are most affected due to reliance on imported hardware. Smaller clinics face adoption delays because of higher upfront costs. However, tariffs are encouraging local sourcing and cloud-based deployments. This shift is improving long-term cost efficiency and regional resilience.
The artificial intelligence (AI) medical scribe software refers to the industry focused on developing and providing artificial intelligence-driven tools that assist healthcare professionals in documenting patient encounters. These solutions automate clinical note-taking, reduce administrative burden, and improve the accuracy and efficiency of medical records.
The primary components of artificial intelligence (AI) medical scribe software include software and services. Software refers to AI-driven medical documentation solutions that use speech recognition, natural language processing, and machine learning to automatically record, transcribe, and organize clinical conversations into accurate medical records. The solutions are deployed through cloud-based and on-premises modes based on data security, regulatory compliance, and infrastructure requirements. The various applications involved include hospitals, clinics, ambulatory surgical centers, specialty centers, and other applications. The end users of AI medical scribe software include healthcare providers, medical institutions, and other end users.
The artificial intelligence (AI) medical scribe software market consists of revenues earned by entities by providing services such as implementation, customization, training, technical support, data integration, cloud hosting, software maintenance and consulting, workflow optimization, compliance management. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) medical scribe software market includes sales of voice recognition devices, servers, tablets, smartphones, digital recorders, wearable microphones, networking hardware, cloud storage devices, transcription headsets and medical workstations. Values in this market are ‘factory gate’ values, and that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The artificial intelligence (AI) medical scribe software market research report is one of a series of new reports that provides artificial intelligence (AI) medical scribe software market statistics, including artificial intelligence (AI) medical scribe software industry global market size, regional shares, competitors with a artificial intelligence (AI) medical scribe software market share, detailed artificial intelligence (AI) medical scribe software market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) medical scribe software industry. This artificial intelligence (AI) medical scribe software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Artificial Intelligence (AI) Medical Scribe Software Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses artificial intelligence (ai) medical scribe software market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for artificial intelligence (ai) medical scribe software? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) medical scribe software market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Component: Software; Services2) By Deployment Mode: Cloud-Based; On-Premises
3) By Application: Hospitals; Clinics; Ambulatory Surgical Centers; Specialty Centers; Other Applications
4) By End-User: Healthcare Providers; Medical Institutions; Other End-Users
Subsegments:
1) By Software: Clinical Documentation Software; Speech Recognition Software; Natural Language Processing Software; Workflow Automation Software; Analytics and Reporting Software2) By Services: Consulting and Advisory Services; Implementation and Integration Services; Training and Education Services; Support and Maintenance Services; Customization and Optimization Services
Companies Mentioned: TruBridge Inc; Innovaccer Inc; CureMDcom Inc; Abridge AI Inc; OmniMD Inc; Notable Health Inc; Nabla Labs Inc; Voicebrook Inc; Tandem Health AB; Sully AI Inc; Freed AI Inc; Heidi Health Pty Ltd; Ambience Healthcare Pty Ltd; Upheal Inc; Tali AI Inc; ScribeAmerica AI Inc; Playback Health Inc; SPRY Therapeutics Inc.; Suki AI Inc; and Sunoh AI Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this AI Medical Scribe Software market report include:- TruBridge Inc
- Innovaccer Inc
- CureMDcom Inc
- Abridge AI Inc
- OmniMD Inc
- Notable Health Inc
- Nabla Labs Inc
- Voicebrook Inc
- Tandem Health AB
- Sully AI Inc
- Freed AI Inc
- Heidi Health Pty Ltd
- Ambience Healthcare Pty Ltd
- Upheal Inc
- Tali AI Inc
- ScribeAmerica AI Inc
- Playback Health Inc
- SPRY Therapeutics Inc.
- Suki AI Inc
- and Sunoh AI Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | March 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.94 Billion |
| Forecasted Market Value ( USD | $ 5.08 Billion |
| Compound Annual Growth Rate | 27.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |


